JUBILANT PHARMOVA
|
JUBILANT PHARMOVA Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
| Equity - Authorised | ₹143 Cr | ₹143 Cr | ₹143 Cr | ₹143 Cr | ₹143 Cr |
| Equity - Issued | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
| Equity Paid Up | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
| Equity Shares Forfeited | - | - | - | - | ₹0.00 Cr |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
| Share Warrants & Outstandings | ₹19 Cr | ₹15 Cr | ₹15 Cr | ₹6.20 Cr | ₹3.66 Cr |
| Total Reserves | ₹7,058 Cr | ₹6,224 Cr | ₹5,404 Cr | ₹5,377 Cr | ₹5,299 Cr |
| Securities Premium | - | - | - | - | - |
| Capital Reserves | ₹-48 Cr | ₹-30 Cr | ₹-25 Cr | ₹2.10 Cr | ₹6.13 Cr |
| Profit & Loss Account Balance | ₹5,608 Cr | ₹5,302 Cr | ₹4,540 Cr | ₹4,537 Cr | ₹4,685 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | ₹1,498 Cr | ₹952 Cr | ₹889 Cr | ₹838 Cr | ₹608 Cr |
| Reserve excluding Revaluation Reserve | ₹7,058 Cr | ₹6,224 Cr | ₹5,404 Cr | ₹5,377 Cr | ₹5,299 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹7,093 Cr | ₹6,255 Cr | ₹5,434 Cr | ₹5,399 Cr | ₹5,319 Cr |
| Minority Interest | ₹2.80 Cr | ₹-16 Cr | ₹-13 Cr | ₹-7.50 Cr | ₹-2.16 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹378 Cr | ₹237 Cr | ₹299 Cr | ₹265 Cr | ₹201 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹297 Cr | ₹124 Cr | ₹157 Cr | ₹151 Cr | ₹474 Cr |
| Term Loans - Institutions | ₹81 Cr | ₹114 Cr | ₹142 Cr | ₹114 Cr | ₹126 Cr |
| Other Secured | - | - | - | - | ₹-399 Cr |
| Unsecured Loans | ₹2,594 Cr | ₹1,913 Cr | ₹2,868 Cr | ₹2,845 Cr | ₹2,263 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | ₹2,594 Cr | ₹1,913 Cr | ₹2,868 Cr | ₹2,845 Cr | ₹756 Cr |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | ₹1,507 Cr |
| Deferred Tax Assets / Liabilities | ₹-6.40 Cr | ₹-85 Cr | ₹-22 Cr | ₹79 Cr | ₹142 Cr |
| Deferred Tax Assets | ₹760 Cr | ₹750 Cr | ₹601 Cr | ₹538 Cr | ₹425 Cr |
| Deferred Tax Liability | ₹754 Cr | ₹665 Cr | ₹579 Cr | ₹616 Cr | ₹566 Cr |
| Other Long Term Liabilities | ₹2,506 Cr | ₹1,912 Cr | ₹760 Cr | ₹484 Cr | ₹220 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹160 Cr | ₹119 Cr | ₹100 Cr | ₹92 Cr | ₹96 Cr |
| Total Non-Current Liabilities | ₹5,631 Cr | ₹4,096 Cr | ₹4,006 Cr | ₹3,765 Cr | ₹2,922 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹1,234 Cr | ₹1,005 Cr | ₹856 Cr | ₹821 Cr | ₹568 Cr |
| Sundry Creditors | ₹1,234 Cr | ₹1,005 Cr | ₹856 Cr | ₹821 Cr | ₹568 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹1,028 Cr | ₹844 Cr | ₹733 Cr | ₹552 Cr | ₹839 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹229 Cr | ₹123 Cr | ₹87 Cr | ₹71 Cr | ₹90 Cr |
| Interest Accrued But Not Due | ₹17 Cr | ₹24 Cr | ₹25 Cr | ₹5.70 Cr | ₹13 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹782 Cr | ₹697 Cr | ₹622 Cr | ₹475 Cr | ₹735 Cr |
| Short Term Borrowings | ₹163 Cr | ₹219 Cr | ₹197 Cr | ₹258 Cr | ₹64 Cr |
| Secured ST Loans repayable on Demands | ₹163 Cr | ₹219 Cr | ₹197 Cr | ₹258 Cr | ₹64 Cr |
| Working Capital Loans- Sec | ₹163 Cr | ₹219 Cr | ₹197 Cr | ₹258 Cr | ₹64 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-163 Cr | ₹-219 Cr | ₹-197 Cr | ₹-258 Cr | ₹-64 Cr |
| Short Term Provisions | ₹114 Cr | ₹97 Cr | ₹103 Cr | ₹141 Cr | ₹121 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹20 Cr | ₹18 Cr | ₹37 Cr | ₹62 Cr | ₹35 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹94 Cr | ₹78 Cr | ₹66 Cr | ₹78 Cr | ₹87 Cr |
| Total Current Liabilities | ₹2,539 Cr | ₹2,165 Cr | ₹1,889 Cr | ₹1,772 Cr | ₹1,592 Cr |
| Total Liabilities | ₹15,266 Cr | ₹12,499 Cr | ₹11,316 Cr | ₹10,929 Cr | ₹9,830 Cr |
| ASSETS | |||||
| Gross Block | ₹10,167 Cr | ₹7,823 Cr | ₹7,869 Cr | ₹7,368 Cr | ₹6,759 Cr |
| Less: Accumulated Depreciation | ₹3,202 Cr | ₹2,647 Cr | ₹2,778 Cr | ₹2,185 Cr | ₹1,888 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹6,966 Cr | ₹5,176 Cr | ₹5,091 Cr | ₹5,183 Cr | ₹4,871 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹2,962 Cr | ₹2,715 Cr | ₹1,252 Cr | ₹773 Cr | ₹292 Cr |
| Non Current Investments | ₹61 Cr | ₹44 Cr | ₹42 Cr | ₹256 Cr | ₹239 Cr |
| Long Term Investment | ₹61 Cr | ₹44 Cr | ₹42 Cr | ₹256 Cr | ₹239 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹61 Cr | ₹44 Cr | ₹42 Cr | ₹256 Cr | ₹239 Cr |
| Long Term Loans & Advances | ₹66 Cr | ₹54 Cr | ₹192 Cr | ₹162 Cr | ₹118 Cr |
| Other Non Current Assets | ₹23 Cr | ₹18 Cr | ₹11 Cr | ₹4.10 Cr | ₹3.98 Cr |
| Total Non-Current Assets | ₹11,156 Cr | ₹8,922 Cr | ₹7,440 Cr | ₹7,167 Cr | ₹6,320 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹1,232 Cr | ₹1,129 Cr | ₹1,290 Cr | ₹1,381 Cr | ₹1,255 Cr |
| Raw Materials | ₹406 Cr | ₹332 Cr | ₹425 Cr | ₹433 Cr | ₹364 Cr |
| Work-in Progress | ₹348 Cr | ₹331 Cr | ₹350 Cr | ₹453 Cr | ₹379 Cr |
| Finished Goods | ₹223 Cr | ₹229 Cr | ₹264 Cr | ₹242 Cr | ₹252 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹150 Cr | ₹162 Cr | ₹174 Cr | ₹178 Cr | ₹156 Cr |
| Other Inventory | ₹104 Cr | ₹75 Cr | ₹77 Cr | ₹74 Cr | ₹103 Cr |
| Sundry Debtors | ₹1,070 Cr | ₹892 Cr | ₹916 Cr | ₹961 Cr | ₹928 Cr |
| Debtors more than Six months | ₹52 Cr | ₹80 Cr | ₹114 Cr | ₹112 Cr | ₹46 Cr |
| Debtors Others | ₹1,051 Cr | ₹879 Cr | ₹869 Cr | ₹900 Cr | ₹908 Cr |
| Cash and Bank | ₹1,268 Cr | ₹1,089 Cr | ₹957 Cr | ₹1,014 Cr | ₹984 Cr |
| Cash in hand | - | - | - | ₹0.10 Cr | ₹0.04 Cr |
| Balances at Bank | ₹1,267 Cr | ₹1,089 Cr | ₹956 Cr | ₹1,011 Cr | ₹979 Cr |
| Other cash and bank balances | ₹0.40 Cr | ₹0.10 Cr | ₹1.20 Cr | ₹3.20 Cr | ₹5.06 Cr |
| Other Current Assets | ₹220 Cr | ₹154 Cr | ₹242 Cr | ₹135 Cr | ₹111 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | ₹1.00 Cr | ₹1.00 Cr | ₹0.90 Cr | ₹0.70 Cr | ₹1.10 Cr |
| Prepaid Expenses | ₹104 Cr | ₹105 Cr | ₹91 Cr | ₹90 Cr | ₹83 Cr |
| Other current_assets | ₹115 Cr | ₹48 Cr | ₹150 Cr | ₹44 Cr | ₹26 Cr |
| Short Term Loans and Advances | ₹321 Cr | ₹246 Cr | ₹228 Cr | ₹271 Cr | ₹231 Cr |
| Advances recoverable in cash or in kind | ₹136 Cr | ₹137 Cr | ₹115 Cr | ₹138 Cr | ₹99 Cr |
| Advance income tax and TDS | ₹71 Cr | ₹18 Cr | ₹17 Cr | ₹12 Cr | ₹0.18 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹114 Cr | ₹91 Cr | ₹96 Cr | ₹122 Cr | ₹132 Cr |
| Total Current Assets | ₹4,109 Cr | ₹3,510 Cr | ₹3,632 Cr | ₹3,762 Cr | ₹3,509 Cr |
| Net Current Assets (Including Current Investments) | ₹1,570 Cr | ₹1,345 Cr | ₹1,743 Cr | ₹1,990 Cr | ₹1,918 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹15,266 Cr | ₹12,499 Cr | ₹11,316 Cr | ₹10,929 Cr | ₹9,830 Cr |
| Contingent Liabilities | ₹419 Cr | ₹368 Cr | ₹456 Cr | ₹402 Cr | ₹420 Cr |
| Total Debt | ₹3,220 Cr | ₹2,437 Cr | ₹3,414 Cr | ₹3,410 Cr | ₹2,928 Cr |
| Book Value | - | 394.94 | 343.00 | 339.19 | 333.91 |
| Adjusted Book Value | 447.70 | 394.94 | 343.00 | 339.19 | 333.91 |
Compare Balance Sheet of peers of JUBILANT PHARMOVA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JUBILANT PHARMOVA | ₹14,828.4 Cr | -3.5% | -3.9% | -20.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
JUBILANT PHARMOVA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JUBILANT PHARMOVA | -3.5% |
-3.9% |
-20.6% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses